Evasc has announced that Robert Greene has joined its Board of Directors. Robert was previously the Chief Technology Officer and Co-Founder at MicroVention Inc. based in Aliso Viejo, CA. MicroVention develops catheter-based, minimally invasive, neuro-endovascular technologies for cerebral aneurysms, and other neurovascular diseases. From 1998, he held the position of Senior Vice-President of Research and Development and moved into the CTO role several years later, playing a key role in Terumo Corporation’s acquisition of Microvention, and later Terumo’s acquisition of Sequent and its primary product, the Woven Endobridge (WEB) device. Prior to working at MicroVention Inc, Rob worked at Vesica Medical, also based in CA. Rob received a Bachelor's degree in Industrial Technology from California State University. Rob is retired and enjoying official and unofficial consultant and advisory roles, and his grandchildren.
"We believe Rob will be helpful in guiding Evasc to commercial success over the near term," said Dr. Donald Ricci, President and Chief Executive Officer of Evasc.
eCLIPs is a non-tubular endovascular device currently targeted for use in challenging wide-neck bifurcations, but whose technology is designed to treat 95% of cerebral aneurysm cases. eCLIPs’ unique design provides not only coil retention, but also flow diversion at the neck. eCLIPs avoids dangerous entry into the dynamic, fragile environment of the aneurysm sac while leaving side branches unencumbered and providing a platform for endothelial growth across the bifurcation neck.
Evasc is a privately-held medical device company focused on the development of disruptive endovascular treatments for cerebral aneurysms. Evasc is headquartered in Vancouver, Canada.
Evasc is on the web at www.evasc.com.
For more information, contact Scott Wilson at +1 (604) 742-3811, email@example.com.